NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) announced that its independent directors approved an equity award under the company's 2021 Inducement Plan, effective June 24, 2026. The award was granted as a material inducement to an individual entering into employment with the company, in compliance with Nasdaq Listing Rule 5635(c)(4), which requires public disclosure of equity awards not made under a stockholder-approved plan.
The individual, who was not a previous employee or director of NeuroOne, received an option to purchase 10,000 shares of common stock. The exercise price is $3.27 per share, the closing price on the grant date. The option has a ten-year term and vests over four years, with 25% vesting on June 24, 2027, and the remainder in 12 equal quarterly installments thereafter, subject to continued employment and acceleration or forfeiture under certain conditions.
This inducement grant highlights NeuroOne's strategy to attract key talent by offering equity incentives outside of stockholder-approved plans, a practice allowed under Nasdaq rules. The company, based in Eden Prairie, Minnesota, focuses on medical technology for neurological disorders, with FDA-cleared products including Evo Cortical Electrodes, Evo sEEG Electrodes, OneRF Ablation System, and OneRF Trigeminal Nerve Ablation System. The company is also researching drug delivery, basivertebral nerve ablation, and spinal cord stimulation.
NeuroOne's commitment to innovation is evident in its electrode technology platform, which aims to reduce hospitalizations and surgical procedures while improving patient outcomes. The inducement grant underscores the company's need for specialized talent to advance its pipeline. For more details on NeuroOne's technologies, visit nmtc1.com.
The announcement aligns with regulatory requirements for transparency, providing investors with information on executive compensation that may impact shareholder value. As NeuroOne continues to develop its product portfolio, such grants are crucial for building a skilled workforce to drive growth.
